1. Home
  2. WOR vs OGN Comparison

WOR vs OGN Comparison

Compare WOR & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WOR
  • OGN
  • Stock Information
  • Founded
  • WOR 1955
  • OGN 1923
  • Country
  • WOR United States
  • OGN United States
  • Employees
  • WOR N/A
  • OGN N/A
  • Industry
  • WOR Aerospace
  • OGN Biotechnology: Pharmaceutical Preparations
  • Sector
  • WOR Consumer Discretionary
  • OGN Health Care
  • Exchange
  • WOR Nasdaq
  • OGN Nasdaq
  • Market Cap
  • WOR 2.7B
  • OGN 2.7B
  • IPO Year
  • WOR N/A
  • OGN N/A
  • Fundamental
  • Price
  • WOR $56.35
  • OGN $10.25
  • Analyst Decision
  • WOR Buy
  • OGN Buy
  • Analyst Count
  • WOR 3
  • OGN 3
  • Target Price
  • WOR $61.00
  • OGN $17.33
  • AVG Volume (30 Days)
  • WOR 378.3K
  • OGN 3.6M
  • Earning Date
  • WOR 09-23-2025
  • OGN 10-30-2025
  • Dividend Yield
  • WOR 1.21%
  • OGN 0.78%
  • EPS Growth
  • WOR 179.34
  • OGN N/A
  • EPS
  • WOR 2.14
  • OGN 2.69
  • Revenue
  • WOR $1,200,161,000.00
  • OGN $6,281,000,000.00
  • Revenue This Year
  • WOR $14.93
  • OGN N/A
  • Revenue Next Year
  • WOR $4.45
  • OGN $0.79
  • P/E Ratio
  • WOR $26.36
  • OGN $3.82
  • Revenue Growth
  • WOR 0.76
  • OGN N/A
  • 52 Week Low
  • WOR $37.88
  • OGN $8.01
  • 52 Week High
  • WOR $70.91
  • OGN $19.05
  • Technical
  • Relative Strength Index (RSI)
  • WOR 36.07
  • OGN 56.23
  • Support Level
  • WOR $54.65
  • OGN $10.52
  • Resistance Level
  • WOR $56.63
  • OGN $11.29
  • Average True Range (ATR)
  • WOR 1.49
  • OGN 0.32
  • MACD
  • WOR -0.07
  • OGN -0.01
  • Stochastic Oscillator
  • WOR 42.28
  • OGN 51.37

About WOR Worthington Enterprises Inc.

Worthington Enterprises Inc is a designer and manufacturer of products and services, including manufactured metal products. The company operates under two reportable operating segments: Consumer Products and Building Products. The consumer Products business has a diverse product offering in the tools, outdoor living and celebrations categories, including propane-filled cylinders for torches, handheld torches, specialized hand tools, drywall tools, accessories and gas grills, and others. And the Building Products business engaged in providing pressurized containment solutions, providing critical components in the residential, non-residential, and repair and remodel end markets through essential categories. The company derives majority of the revenue from Building Products segment.

About OGN Organon & Co.

Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.

Share on Social Networks: